Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
European Surgery
Published in: European Surgery 3/2018

Open Access 01-06-2018 | main topic

Perioperative management of liver surgery—review on pathophysiology of liver disease and liver failure

Authors: Lukas Gasteiger, Stephan Eschertzhuber, Werner Tiefenthaler

Published in: European Surgery | Issue 3/2018

Login to get access

Summary

An increasing number of patients present for liver surgery. Given the complex pathophysiological changes in chronic liver disease (CLD), it is pivotal to understand the fundamentals of chronic and acute liver failure. This review will give an overview on related organ dysfunction as well as recommendations for perioperative management and treatment of liver failure-related symptoms.
Literature
1.
Miller RD, Eriksson LI, Fleisher LA, Wiener-Kronish JP. Miller’s anesthesia. 8th ed. Churchill Livingston: Elsevier; 2014.
2.
Morgan GE Jr, Mikhail MS, Murray MJ. Clinical anesthesiology. 4th ed. 2006.
3.
Kristensen, et al. 2014 ESC/ESA guidelines noon n‑cardiac surgery: cardiovascular assessment and management. Eur Heart J. 2014;35:2383–431.CrossRefPubMed
4.
Iwakiri YY, Groszmann RJ. The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule. Hepatology. 2006;43:S121–S31.CrossRefPubMed
5.
6.
Bolognesi M, Di Pascoli M, Verardo A, Gatta A. Splanchnic vasodilation and hyperdynamic circulatory syndrome in cirrhosis. World J Gastroenterol. 2014;20(10):2555–63.CrossRefPubMedPubMedCentral
7.
Mookerjee RP, Balasubramaniyan V, Mehta G. ADMA and hepatic endothelial dysfunction in cirrhosis—the DDAH isoform is the key. Liver Int. 2012;32:1186. author reply 1187.CrossRefPubMed
8.
Mookerjee RP, Vairappan B, Jalan R. The puzzle of endothelial nitric oxide synthase dysfunction in portal hypertension: the missing piece? Hepatology. 2007;46:943–6.CrossRefPubMed
9.
Herz S, Puhl G, Spies C, Jörres D, Neuhaus P, von Heymann C. Perioperatives anästhesiologisches Management bei ausgedehnten Leberteilresektionen. Anaesthesist. 2011;60:103–17.CrossRefPubMed
10.
11.
Ruiz-del-Árbol L, Monescillo A, Arocena C, et al. Circulaztory function and hepatorenal syndrome in cirrhosis. Hepatology. 2005;42:439–47.CrossRefPubMed
12.
Arroyo V, Gine’s P, Alexander L, Gerbes AL, Dudley FJ, Gentilini P, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology. 1996;23:164–76.CrossRefPubMed
13.
Fernandez-Seara J, Prieto J, Quiroga J, Zozaya JM, Cobos MA, Rodriguez-Eire JL, et al. Systemic and regional hemodynamics in patients with liver cirrhosis and ascites with and without functional renal failure. Gastroenterology. 1989;97:1304–12.CrossRefPubMed
14.
Sagi S, Mittal S, Kasturi KS, Sood GK. Terlipressin therapy for reversal of type 1 hepatorenal syndrome: a meta-analysis of randomized controlled trials. J Gastroenterol Hepatol. 2010;25:880–5.CrossRefPubMed
15.
16.
Ramsay M. Portopulmonary hypertension and right heart failure in patients with cirrhosis. Curr Opin Anaesthesiol. 2010;23:145–50.CrossRefPubMed
17.
Hoeper MM, Krowka MJ, Strassburg CP. Portopulmonary hypertension and hepatopulmonary syndrome. Lancet. 2004;363:1461–8.CrossRefPubMed
18.
Krowka MJ, Miller DP, Barst RJ, et al. Portopulmonary hypertension-a report from the US-based REVEAL registry. Chest. 2012;141(4):906–15.CrossRefPubMed
19.
Krowka MJ, Swanson KL, Frantz RP, et al. Portopulmonary hypertension: results from a 10-year screening algorithm. Hepatology. 2006;44:1502–10.CrossRefPubMed
20.
Maithel SK, Kneuertz PJ, Kooby DA, et al. Importance of low preoperative platelet count in selecting patients for resection of hepatocellular carcinoma: a multiinstitutional analysis. J Am Coll Surg. 2011;212:638–48.CrossRefPubMedPubMedCentral
21.
Weeder PD, Porte RJ, Lisman T. Hemostasis in liver disease: implications of new concepts for perioperative management. Transfus Med Rev. 2014;28:107–13.CrossRefPubMed
22.
Lisman T, Porte R. Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences. Blood. 2010;116:878–85.CrossRefPubMed
23.
Tripodi A, Salerno F, Chantarangkul V, et al. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests. Hepatology. 2005;41:553–8.CrossRefPubMed
24.
Lisman T, Bakhtiari K, Pereboom IT, Hendriks HG, Meijers JC, Porte RJ. Normal to increased thrombin generation in patients undergoing liver transplantation despite prolonged conventional coagulation tests. J Hepatol. 2010;52:355–61.CrossRefPubMed
25.
Stravitz RT. Potential applications of thromboelastography in patients with acute and chronic liver disease gastroenterology. Hepatology. 2012;8(8):513–20.
26.
Hoetzel A, Ryan H, Schmidt R. Anesthetic considerations for the patient with liver disease. Curr Opin Anaesthesiol. 2012;25:340–7.CrossRefPubMed
27.
28.
O’Connor Z, Zafirova M. Hepatic encephalopathy: current management strategies and treatment, including management and monitoring of cerebral edema and intracranial hypertension in fulminant hepatic failure. Curr Opin Anaesthesiol. 2010;23:121–7.CrossRefPubMed
29.
30.
31.
32.
Ginés P, Quintero E, Arroyo V, Terés J, Bruguera M, Rimola A, Caballería J, Rodés J, Rozman C. Compensated cirrhosis: natural history and prognostic factors. Hepatology. 1987;7:122–8.CrossRefPubMed
33.
Planas R, Montoliu S, Ballesté B, Rivera M, Miquel M, Masnou H, Galeras JA, Giménez MD, Santos J, Cirera I, Morillas RM, Coll S, Solà R. Natural history of patients hospitalized for management of cirrhotic ascites. Clin Gastroenterol Hepatol. 2006;4:1385–94.CrossRefPubMed
34.
Roberts LR, Kamath PS. Ascites and hepatorenal syndrome: pathophysiology and management. Mayo Clin Proc. 1996;71:874–81.CrossRefPubMed
35.
Starczewska MH, Mon W, Shirley P. Anaesthesia in patients with liver disease. Curr Opin Anaesthesiol. 2017;30:392–8.CrossRefPubMed
36.
Garg RK. Anesthetic considerations in patients with hepatic failure. Int Anesthesiol Clin. 2005;43:45–63.CrossRefPubMed
37.
38.
Cho HC, Jung HY, Sinn DH, et al. Mortality after surgery in patients with liver cirrhosis: comparison of Child-Turcotte-Pugh, MELD and MELDNa score. Eur J Gastroenterol Hepatol. 2011;23:51–9.CrossRefPubMed
39.
Suman A, Carey WD. Assessing the risk of surgery in patients with liver disease. Cleve Clin J Med. 2006;73:398–404.CrossRefPubMed
40.
Teh SH, Nagorney DM, Stevens SR, et al. Risk factor for mortality after surgery in patient s with cirrhosis. Gastroenterology. 2007;132(4):1261.CrossRefPubMed
41.
Ghaferi AA, Mathur AK, Sonnenday CJ, Dimick JB. Adverse outcomes in patients with chronic liver disease undergoing colorectal surgery. Ann Surg. 2010;252:345–50.CrossRefPubMed
42.
Lentschener C, Flaujac C, Ibrahim F, et al. Assessment of haemostasis in patients with cirrhosis: relevance of the ROTEM tests?: a prospective, crosssectional study. Eur J Anaesthesiol. 2016;33:126–33.CrossRefPubMed
43.
Eschertzhuber S, Lindner KH, Hörmann C. Anästhesie für die Lebertransplantation (LTX). Anasthesiol Intensivmed Notfallmed Schmerzther. 2007;42(10):682–9.CrossRefPubMed
44.
Salerno F, Navickis RJ, Wilkes MM. Albumin treatment regimen for type 1hepatorenal syndrome: a dose-response meta-analysis. BMC Gastroenterol. 2015;15:167.CrossRefPubMedPubMedCentral
45.
Postlewait LM, et al. The relationship of blood transfusion with peri-operative and long-term outcomes after major hepatectomy for metastatic colorectal cancer: a multi-institutional study of 456 patients. HPB (Oxford). 2016;18:192–9.CrossRef
46.
Hughes MJ, Ventham NT, Harrison EM, Wigmore SJ. Central venous pressure and liver resection: a systematic review and meta-analysis. HPB (Oxford). 2015;17(10):863–71.CrossRef
47.
Li Z, Sun YM, Wu FX, Yang LQ, Lu ZJ, Yu WF. Controlled low central venous pressure reduces blood loss transfusion requirements in hepatectomy. World J Gastroenterol. 2014;20(1):303–9.CrossRefPubMedPubMedCentral
48.
Correa-Gallego C, Berman A, Langdon-Embry L, et al. Renal function after low central pressure-assisted liver resection:assesmment of 2016. HPB (Oxford). 2015;17(3):258–64.CrossRef
49.
Dünser M, Kwizera A. Perioperative fluid management. Eur Surg. 2017;49:41–8.CrossRef
50.
Mizota T, Yamamoto Y, Hamada M, Matsukawa S, Shimizu S, Kai S. Intraoperative oliguria predicts acute kidney injury after major abdominal surgery. Br J Anaesth. 2017;119(6):1127–34.CrossRefPubMed
Metadata
Title
Perioperative management of liver surgery—review on pathophysiology of liver disease and liver failure
Authors
Lukas Gasteiger
Stephan Eschertzhuber
Werner Tiefenthaler
Publication date
01-06-2018
Publisher
Springer Vienna
Published in
European Surgery / Issue 3/2018
Print ISSN: 1682-8631
Electronic ISSN: 1682-4016
DOI
https://doi.org/10.1007/s10353-018-0522-4

Other articles of this Issue 3/2018

European Surgery 3/2018 Go to the issue

main topic

Shaping the future of liver surgery

main topic

Patient selection and perioperative optimisation in surgery for colorectal liver metastases

main topic

Optimal perioperative care in peri-hilar cholangiocarcinoma resection

main topic

Surgical techniques and strategies for the treatment of primary liver tumours: hepatocellular and cholangiocellular carcinoma

main topic

Liver resection for non-colorectal metastases

main topic

Technical advances and future perspectives in liver surgery